Source of support: Self financing Lung transplantation remains the gold standard for patients with end-stage lung disease. Nevertheless, the number of suitable donor lungs for the increasing number of patients on the waiting list necessitates alterna-tive tools to expand the lung donor pool. Modern preservation and lung assessment techniques could contrib-ute to improved function in previously rejected lungs. Ex vivo lung perfusion (EVLP) already demonstrated its value in identification of transplantable grafts from the higher risk donor pool. Moreover, lungs from EVLP did not show significantly different postoperative results compared to standard criteria lungs. This could be explained by the reduction of the ischemia-reperfusion in-jury t...
Since its advent in the 1990′s, ex vivo lung perfusion (EVLP) has been studied and implemented as a ...
Lung transplantation is limited by a scarcity of suitable donors resulting in high waiting list mort...
Lung transplantation (Ltx) is the only life-saving treatment for selected patients with end-stage pu...
Background Among the strategies to increase the number of lung transplants, ex vivo lung perfusion (...
Lung transplantation is a lifesaving treatment in numerous forms of end-stage lung disease but organ...
Donor lung shortage has been the main reason to the increasing number of patients waiting for lung t...
Ex vivo lung perfusion (EVLP) is currently used for both standard and extended-criteria donor (ECD) ...
The number of patients listed for lung transplantation largely exceeds the number of available trans...
Since its advent in the 1990′s, ex vivo lung perfusion (EVLP) has been studied and implemented as a ...
This paper describes the initial clinical experience of ex-vivo lung perfusion (EVLP) at the Fondazi...
BACKGROUND: Only about 15% of donor lungs are considered suitable for transplantation (LTx). Ex vivo...
Lung transplantation is a lifesaving therapeutic option for a variety of endstage cardiopulmonary co...
OBJECTIVES: Despite progress in lung transplantation (LTx) techniques, a shortage of donor lungs per...
Ex vivo lung perfusion (EVLP) has been validated as a valuable technique to increase the pool of org...
ex vivo lung perfusion (EVLP) potentially allows to reduce the donor pool shortage, however its effi...
Since its advent in the 1990′s, ex vivo lung perfusion (EVLP) has been studied and implemented as a ...
Lung transplantation is limited by a scarcity of suitable donors resulting in high waiting list mort...
Lung transplantation (Ltx) is the only life-saving treatment for selected patients with end-stage pu...
Background Among the strategies to increase the number of lung transplants, ex vivo lung perfusion (...
Lung transplantation is a lifesaving treatment in numerous forms of end-stage lung disease but organ...
Donor lung shortage has been the main reason to the increasing number of patients waiting for lung t...
Ex vivo lung perfusion (EVLP) is currently used for both standard and extended-criteria donor (ECD) ...
The number of patients listed for lung transplantation largely exceeds the number of available trans...
Since its advent in the 1990′s, ex vivo lung perfusion (EVLP) has been studied and implemented as a ...
This paper describes the initial clinical experience of ex-vivo lung perfusion (EVLP) at the Fondazi...
BACKGROUND: Only about 15% of donor lungs are considered suitable for transplantation (LTx). Ex vivo...
Lung transplantation is a lifesaving therapeutic option for a variety of endstage cardiopulmonary co...
OBJECTIVES: Despite progress in lung transplantation (LTx) techniques, a shortage of donor lungs per...
Ex vivo lung perfusion (EVLP) has been validated as a valuable technique to increase the pool of org...
ex vivo lung perfusion (EVLP) potentially allows to reduce the donor pool shortage, however its effi...
Since its advent in the 1990′s, ex vivo lung perfusion (EVLP) has been studied and implemented as a ...
Lung transplantation is limited by a scarcity of suitable donors resulting in high waiting list mort...
Lung transplantation (Ltx) is the only life-saving treatment for selected patients with end-stage pu...